Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management.
Ontology highlight
ABSTRACT: Colorectal cancer (CRC) poses a significant threat to many human lives worldwide and survival following resection is predominantly stage dependent. For early-stage cancer, patients are not routinely advised to undergo additional post-operative adjuvant chemotherapy. Acceptable clinical management guidelines are well established for patients in pTNM stages I, III and IV. However, recommendations for managing CRC stage II patients remain controversial and many studies have been conducted to segregate stage II patients into low- and high-risk of recurrence using genomic, transcriptomic and proteomic molecular markers. As proteins provide valuable insights into cellular functions and disease state and have a relatively easy translation to the clinic, this review aims to discuss potential progn
SUBMITTER: Alnakli AAA
PROVIDER: S-EPMC11523985 | biostudies-literature | 2024 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA